STOCK TITAN

Delphx Cap Mkts Stock Price, News & Analysis

DPXCF OTC

Welcome to our dedicated page for Delphx Cap Mkts news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on Delphx Cap Mkts stock.

DelphX Capital Markets Inc. (OTCQB: DPXCF) generates news that reflects its focus on structured products at the intersection of fixed-income and cryptocurrency markets. The company’s disclosures highlight product development, capital-raising transactions, and initiatives related to its Quantem Crypto Securities (QCS) program.

Recent announcements have emphasized non-brokered private placements of units composed of common shares and warrants, with proceeds intended for working capital, corporate overhead, or general corporate purposes. These updates often include details on warrant terms, related party participation, and the need for TSX Venture Exchange approval, offering insight into how DelphX funds its activities and manages its capital structure.

Another key theme in DelphX news is the evolution of its QCS hedging solution. The company has reported marketing efforts to digital-asset treasuries and institutional participants, interest from a U.S. primary dealer evaluating a proof-of-concept deployment, and due diligence by multiple crypto-asset treasuries. It has also announced a non-binding letter of intent with Belgravia Hartford Capital Inc. for a potential first commercial QCS transaction aimed at protecting corporate Bitcoin treasury holdings.

Corporate governance and compensation developments also appear in DelphX news, including stock option grants under its option plan and transitions in the Chief Financial Officer role. For investors and observers, the DPXCF news stream offers ongoing context on product commercialization efforts, financing activities, and the company’s positioning within structured credit and digital-asset hedging.

Users following DelphX news can review these recurring topics to monitor how the company advances its proprietary CPO, CRN, and QCS offerings, and how regulatory approvals, market conditions, and institutional engagement influence its trajectory.

Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has completed its previously announced non-brokered private placement, raising C$459,350 through the issuance of 6,562,142 units at C$0.07 per unit. Each unit comprises one common share and one purchase warrant, with warrants exercisable at C$0.08 for five years.

Company insiders participated by subscribing for 1,545,000 units. The offering includes a C$4,900 cash finder's fee and 70,000 finders' warrants to AlphaNorth Asset Management. The securities will have a four-month plus one-day hold period, and the proceeds will be used for general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.57%
Tags
private placement
-
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has announced an oversubscribed non-brokered private placement offering of 7,090,715 units at C$0.07 per unit, targeting gross proceeds of C$496,350.

Each unit comprises one common share and one purchase warrant, with warrants exercisable at C$0.08 per share for a five-year period. The company will pay cash finder's fees and issue finders' warrants to eligible finders, exercisable at C$0.08 for five years.

The offering requires TSX Venture Exchange approval and includes a four-month plus one-day hold period. Company insiders may participate in the placement, and proceeds will support general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.57%
Tags
private placement
-
News
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a company focused on developing structured products for the fixed income market, has announced a new stock option grant. The Board of Directors has approved the issuance of 1,100,000 stock options to eligible participants under its stock option plan.

The granted options come with a two-year maturity period and can be exercised at a price of $0.20 per common share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.57%
Tags
none
News
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a company focused on developing structured products for the fixed income market, has announced a new stock option grant. The Board of Directors has approved the issuance of 950,000 stock options to eligible participants under its stock option plan. These options come with a two-year maturity period and can be exercised at $0.20 per common share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.8%
Tags
none
-
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a fixed income structured products developer, has completed a non-brokered private placement raising C$251,040 through the issuance of 2,789,333 units at C$0.09 per unit. Each unit comprises one common share and one purchase warrant, with warrants exercisable at C$0.20 per share for a two-year period.

The offering has received conditional acceptance from the TSX Venture Exchange, pending final requirements. Securities issued will have a four-month plus one-day hold period. The company plans to use the proceeds for general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.8%
Tags
private placement
-
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has completed a non-brokered private placement, raising C$160,200 through the issuance of 1,335,000 units at C$0.12 per unit. Each unit comprises one common share and one purchase warrant, with warrants exercisable at C$0.20 per share for five years.

Insiders participated by subscribing for 85,000 units, making this a 'related party transaction.' The company received conditional acceptance from the TSX Venture Exchange, with final acceptance pending. Securities issued will have a four-month plus one-day hold period. The proceeds will be used for general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.92%
Tags
private placement
News
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a company focused on developing structured products for the fixed income market, has announced a new stock option grant. The Board of Directors has approved 1,750,000 stock options for eligible participants under its stock option plan. These options come with a two-year maturity period and can be exercised at $0.20 per common share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.42%
Tags
none
-
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has announced significant achievements in 2024 and outlined its growth strategy for 2025. The company is preparing to execute its first commercial transactions in Q1 2025, involving downgrade protection coverage on a $3 billion notional value bond portfolio.

The company's Credit Rating Securities (CRS) program has received positive feedback from hedge funds and institutional buyers, with active term sheets already exchanged between parties. This innovative platform enables insurance companies, hedge funds, and institutional investors to manage downgrade risks while generating new returns.

CEO Patrick Wood emphasized that DelphX is delivering the most significant innovation in fixed income markets in over a decade, with the company positioned for increased CRS adoption and positive cash flows in 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.42%
Tags
none
-
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has completed its previously announced non-brokered private placement, raising C$348,100 through the issuance of 2,900,834 units at C$0.12 per unit. Each unit includes one common share and one purchase warrant, exercisable at C$0.20 for five years.

Insiders participated by subscribing for 420,000 units. AlphaNorth Asset Management will receive C$3,528 in finder's fees and 29,400 finders' warrants. The offering, conditionally accepted by TSX Venture Exchange, includes a four-month plus one day hold period for issued securities. Proceeds will be used for general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.42%
Tags
private placement
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces the issuance of 428,571 common shares at a deemed price of C$0.14 per share to a consultant. The shares, valued at C$60,000, are being issued as payment for services related to the Company's Credit Rating Security (CRS) product, including refinement of pricing models, preparation of presentations, and assistance with broker dealer negotiations. Following the issuance, which requires TSX Venture Exchange approval, DelphX will have 182,102,033 common shares outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.28%
Tags
none

FAQ

What is the current stock price of Delphx Cap Mkts (DPXCF)?

The current stock price of Delphx Cap Mkts (DPXCF) is $0.0285 as of March 19, 2026.

What is the market cap of Delphx Cap Mkts (DPXCF)?

The market cap of Delphx Cap Mkts (DPXCF) is approximately 6.1M.

DPXCF Rankings

DPXCF Stock Data

6.09M
157.03M
Capital Markets
Financial Services
Link
Canada
Toronto

DPXCF RSS Feed